Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CTI BIOPHARMA CORP | EVP & Chief Commercial Officer | Common Stock | 0 | $9.10 | Jun 26, 2023 | Direct | |
CTI BIOPHARMA CORP | EVP & Chief Commercial Officer | Stock Option (Right to Buy) | 0 | Jun 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTIC | CTI BIOPHARMA CORP | Jun 26, 2023 | 10 | -$32.4K | 4 | Jun 26, 2023 | EVP & Chief Commercial Officer |
CTIC | CTI BIOPHARMA CORP | Mar 14, 2023 | 1 | $0 | 4 | Mar 16, 2023 | EVP & Chief Commercial Officer |
CTIC | CTI BIOPHARMA CORP | Jan 24, 2023 | 4 | -$505K | 4 | Jan 26, 2023 | EVP & Chief Commercial Officer |
CTIC | CTI BIOPHARMA CORP | Feb 28, 2022 | 0 | $0 | 3 | Mar 11, 2022 | Senior Vice President and Chief Commercial Officer Exhibit 24 - Power of Attorney |